PATENT CLAIM ANALYSIS

Application Number: 15769065
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["544", "242000"]

Abstract:
The invention relates to a salt, a hydrate or a crystalline form of an EGFR inhibitor, and use thereof. Specifically it relates to 4-[(3-chloro-4-fluorophenyl) amino]-7-methoxy-6-[3-[(1R,6S)-2,5-dioxa-8-azabicyclo [4.3.0] nonan-8-yl] propoxy]quinazoline dimethanesulfonate, hydrate and a crystalline form thereof; the invention also relates to a preparation method of the crystalline form disclosed herein, a pharmaceutical composition containing the crystalline form, and uses thereof for treating proliferative disorders.

Claim (Index 5):
The crystalline form of  claim 4  having an X-ray powder diffraction (XRPD) pattern comprising peaks expressed in degrees 2\u03b8 at 9.470\u00b10.2\u00b0, 14.88\u00b0\u00b10.2\u00b0, 16.58\u00b0\u00b10.2\u00b0, 17.15\u00b0\u00b10.2\u00b0, 17.46\u00b0\u00b10.2\u00b0, 18.05\u00b0\u00b10.2\u00b0, 20.46\u00b0\u00b10.2\u00b0, 20.84\u00b0\u00b10.2\u00b0, 21.34\u00b0\u00b10.2\u00b0, 22.71\u00b0\u00b10.2\u00b0, 23.16\u00b0\u00b10.2\u00b0, 24.39\u00b0\u00b10.2\u00b0, 25.18\u00b0\u00b10.2\u00b0, 25.46\u00b0\u00b10.2\u00b0, 26.29\u00b0\u00b10.2\u00b0 and 28.01\u00b0\u00b10.2\u00b0.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 91.0
- Lexical Diversity: 1.71154
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13003216', '15314938', '15778220', '14896992', '15539147']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7554561758461749
- 35 USC 102 Novelty (BERT): 0.4810737218914926
- Combined Prediction Score: 0.7280179304507067
- Mean Citation Score: 210.23572400000003
- Max Citation Score: 218.16515
- Similarity Product: 168.23987439474462

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test